NeoGenomics Reports that its NeoLAB(R) Liquid Biopsy

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
93
NeoGenomics Reports that its NeoLAB(R) Liquid Biopsy Prostate Test is More Accurate than Conventional Biopsies in Predicting High Grade Prostate Cancer

FT. MYERS, FL --(Marketwired - May 15, 2017) - NeoGenomics, Inc. ( NASDAQ : NEO ), a leading provider of cancer-focused genetic testing services, announced the presentation of results of a new clinical trial demonstrating that the sensitivity of its NeoLAB ® Liquid Biopsy Prostatetest was 97% in predicting the presence of high grade prostate cancer (equivalent to a Gleason Score of 7 or higher), while the sensitivity of conventional biopsies in this study was 78%. The data, which was presented this past weekend at the American Urological Association (AUA) 2017 Annual meeting, indicates that the NeoLAB ® Prostate test can be useful in determining which patients should enter into active surveillance programs.

In the blinded prospective clinical trial of 306 patients, NeoGenomics compared the results of its NeoLAB ® Prostate test to biopsy results and to prostatectomy results for each patient. The NeoLAB ® Prostate test was significantly more accurate in predicting the presence of advanced prostate cancer than conventional biopsy when the prostate was examined upon prostatectomy.

According to the American Cancer Society's Cancer Facts and Figures 2017 , approximately 161,000 new cases of prostate cancer are diagnosed annually with approximately 27,000 deaths from prostate cancer occurring each year. Prostate biopsy testing is commonly used to determine the presence or absence of aggressive prostate cancer. However, it is well documented that conventional prostate biopsy testing is frequently inaccurate and not representative of actual prostate cancer due to sampling errors. Studies have shown that in patients with prostate cancer, the level of aggressiveness (grade) is upgraded or downgraded in 30% to 40% of the cases upon examination of the actual prostate as a result of a prostatectomy. This means that some high grade prostate cancers go untreated and some low grade cancers are treated unnecessarily.

Dr. Maher Albitar, the Company's Senior Vice President, Chief Medical Officer and Director of Research and Development, commented, "Today, a major concern for patients and treating physicians is inadvertently enrolling patients with high grade cancer into active surveillance protocols because of sampling errors in biopsies, when they might be better served by beginning aggressive treatment. Thus, confirming the grade of prostate cancer prior to putting patients on active surveillance, and monitoring patients for any change in grade while under active surveillance, are very important."

Dr. Albitar continued, "Our findings not only confirm the reliability of our test in predicting the presence of high grade prostate cancer, but also suggest that our test should be used as an adjunct to biopsy testing for patients being considered for active surveillance. We believe our NeoLAB® Prostate test provides a non-invasive and simple means of testing to confirm the grade of cancer that will enable physicians to make more informed decisions about the selection, monitoring and management of their prostate cancer patients."

Douglas M. VanOort, NeoGenomics' Chairman and Chief Executive Officer, stated "Our NeoLAB ® Liquid Biopsy Prostate test can be very helpful in determining initiation or continuation of an active surveillance protocol for patients with prostate cancer. This is a new indication for this test and an important reason for physicians to utilize the NeoLAB ® Prostate test. Development of this cutting-edge test, which is available now for ordering, confirms our commitment to innovation and our leadership in developing new clinically-reliable tests for cancer detection and management."

A copy of the poster presented to the American Urological Association can be accessed on NeoGenomics Website at http://neogenomics.com/portals/0/pdf/Posters/...itar-M.pdf .

About NeoGenomics, Inc.

NeoGenomics, Inc. specializes in cancer genetics testing and information services. The Company provides one of the most comprehensive oncology-focused testing menus in the world for Physicians to help them diagnose and treat cancer. The Company's Pharma Services division serves pharmaceutical clients in clinical trials and drug development.

Headquartered in Fort Myers, FL, NeoGenomics operates CLIA certified laboratories in Aliso Viejo, Fresno, Irvine, and West Sacramento, California; Tampa and Fort Myers, Florida; Houston, Texas and Nashville, Tennessee. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, integrated service delivery networks, and managed care organizations throughout the United States. For additional information about NeoGenomics, visit www.neogenomics.com .

Forward Looking Statements

Except for historical information, all of the statements, expectations and assumptions contained in the foregoing are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties that could cause actual future results to differ materially from those anticipated in the forward-looking statements. Actual results could differ materially from such statements expressed or implied herein. Factors that might cause such a difference include, among others, the company's ability to continue gaining new customers, offer new types of tests, and otherwise implement its business plan. As a result, this press release should be read in conjunction with the company's periodic filings with the SEC.

For further information, please contact: NeoGenomics, Inc. Steven C. Jones Executive Vice President & Dir. of Investor Relations (239) 325-2001

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Excel Treatment Center Adds ART Trauma Therapy Option

Updated Category News Views 101

Trauma rarely arrives at an addiction program wearing a name tag. Excel Treatment Center in Dover, New Jersey, is responding to that uncomfortable reality by adding Accelerated Resolution Therapy® (ART) to the individual, group, and family therapy already available to its clients. The center says its therapists have completed ART training, and the approach is now part of...

Continue Reading
Linkind's Best Buy Push Tests Smart Outdoor Demand

Updated Category News Views 160

Holiday lights have quietly become a year-round hardware category, and Linkind wants a louder seat at the table. The smart-lighting brand says three outdoor products have been in Best Buy stores across the United States since October 17, 2026: permanent exterior lights, decorative string lights, and solar pathway lights. That is a real distribution step, not some grand...

Continue Reading
Blue Diamond's $1 Billion Brand Meets Farm Realities

Updated Category News Views 56

A Ten-Cent Signal Carries Real Weight A ten-cent edge over the industry benchmark may not excite the cocktail-party crowd, but almond growers notice every penny when fertilizer, power and pest control keep gnawing at the farm gate. Blue Diamond Growers says it delivered payments roughly 10 cents above the benchmark in its latest year, alongside net profit that came in...

Continue Reading
Kendra Scott’s Dolly Tribute Tests Purposeful Luxury

Updated Category News Views 87

Butterflies, music notes, and a $70 pendant are carrying a surprisingly serious brand message this November. Kendra Scott’s new Dolly Parton Tribute Collection is plainly built to celebrate Dolly’s style, but it also shows how a consumer brand can make sentiment do some commercial heavy lifting without turning the whole thing into mush. The collection arrived November...

Continue Reading
Chaos Zero Nightmare's Award Is a Useful Signal for Games

Updated Category News Views 239

A story award can be easy to sneer at until a live-service game earns one across three markets. Smilegate's Chaos Zero Nightmare, a dark fantasy roguelike RPG developed by Super Creative, was named Best Story in Google Play's Best of 2026 awards for Taiwan, Hong Kong and Macau. That is not a sales figure, not a profit disclosure, and certainly not proof that a hit has...

Continue Reading
Vector Adds Mesa Division 10 Veteran for Arizona Growth

Updated Category News Views 61

A toilet-partition deal rarely raises eyebrows, but this one has the sturdy logic investors ought to notice. Vector Building Products has acquired Mesa-based Partitions & Accessories Co., a Division 10 specialist that has served Arizona contractors since 1978. It is not glamorous work. It is, however, the sort of necessary, specification-driven business that gets embedded...

Continue Reading
Chemours Legal Succession Gets a Long Transition Runway

Updated Category News Views 0

A corporate-law handoff rarely sets pulses racing, but this one deserves a proper look. Chemours is replacing its long-serving general counsel while keeping the departing executive in the building for four additional months. That is not flashy, and thank goodness for that. In a global chemicals company, legal leadership touches regulation, compliance, governance,...

Continue Reading
Villa Group’s Punta Mita Bet Adds 305 Luxury Resort Keys

Updated Category News Views 102

A 12.6-acre slice of Riviera Nayarit coastline is about to get a very expensive makeover, assuming The Villa Group can turn a handsome plan into a functioning resort without the usual development headaches. The company says it has acquired a beachfront parcel in Litibú and intends to build Villa La Valencia Punta Mita, a 305-accommodation luxury property aimed squarely...

Continue Reading
Premier Energy's €850M Debt Bet on Evryo Nears Close

Updated Category News Views 27

A Bridge Loan Gives Way to a Real Commitment Eight hundred and fifty million euros is not the sort of number a company tosses around for decoration. Premier Energy has secured a five-year senior facilities agreement to fund its planned acquisition of Evryo Group, including electricity distribution subsidiary Distribu?ie Energie Oltenia S.A., and to refinance roughly...

Continue Reading
Sokin’s UAE License Turns Expansion Into Real Payments Plumbing

Updated Category News Views 106

Dubai expansion headlines are cheap; regulated local money movement is not. That is why Sokin’s newly approved Dubai Financial Services Authority license deserves more than the usual fintech applause line. The company has paired that approval with AED accounts, local payment rails, a One Za’abeel office and a plan to double its UAE staff over the next year. None of...

Continue Reading

Top 5 Most Recently Viewed Articles

Latin Metals Gears Up for Drilling at Organullo Gold Project

Updated Category News Views 176

Latin Metals Achieves Drilling Milestone for Organullo Gold Project Latin Metals Inc. (TSXV: LMS) is excited to announce that it has successfully secured a crucial permit for exploration drilling at the Organullo Gold Project. This approval is a significant step forward in their commitment to mineral exploration in Argentina. What the Drill Permit Means for Latin Metals...

Continue Reading
TheSushiDragon Partners with StreamerDap to Empower Creators

Updated Category News Views 444

TheSushiDragon Joins StreamerDap as Co-Owner In a groundbreaking move for the live streaming community, TheSushiDragon, a prominent Twitch creator, has officially entered an equity partnership with StreamerDap, a leading platform revolutionizing the sponsorship landscape for creators. This innovative partnership aims to enhance the creator experience, making sponsorships...

Continue Reading
Tariffs, Inflation Insights: What Lies Ahead for Markets

Updated Category News Views 198

Market Trends: Understanding Recent Developments The market landscape has shown itself to be quite dynamic recently. As US President Donald Trump indicates the possibility of increased tariffs, there remains a juxtaposition of hope and uncertainty in the air. While discussions of a potential peace agreement between Russia and Ukraine seem to be gaining momentum, this has...

Continue Reading
Chaos Zero Nightmare's Award Is a Useful Signal for Games

Updated Category News Views 239

A story award can be easy to sneer at until a live-service game earns one across three markets. Smilegate's Chaos Zero Nightmare, a dark fantasy roguelike RPG developed by Super Creative, was named Best Story in Google Play's Best of 2026 awards for Taiwan, Hong Kong and Macau. That is not a sales figure, not a profit disclosure, and certainly not proof that a hit has...

Continue Reading
Bloom Energy Partners with Oracle to Boost AI Infrastructure

Updated Category News Views 301

Bloom Energy and Oracle: A Strategic Collaboration Bloom Energy Corp (NYSE: BE) is experiencing a notable surge in its stock prices following a recent announcement that highlights a significant partnership with Oracle Corp (NYSE: ORCL). This new collaboration aims to utilize Bloom's innovative fuel cell technology to deliver onsite power solutions for selected Oracle...

Continue Reading